Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil vs Remifentanil for Postoperative Pain in Robot-assisted Nephrectomy
NCT06260046Not yet recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Mar 2024
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of sufentanil in postoperative pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Opioid consumption at 1 hour. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06260046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06260046.